Trends and Analysis on GlaxoSmithKline plc: PharmaVitae Profile

18-Aug-2011 | News-Press Release

This analysis examines the historical and forecast performance for GlaxoSmithKline in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. ( )
 Features and benefits - Gain insight into GlaxoSmithKline's strategic outlook across the next 6 years. Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source. Highlights - Strategic insight into the prospects for GlaxoSmithKline over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
 Your key questions answered - Benchmark GlaxoSmithKline's performance against key rivals in the prescription pharmaceutical sector. Assess GlaxoSmithKline's continued diversification strategy with vaccines and emerging markets positioned as key growth opportunities. Analyse how life-cycle managment (and a lack of generic competition) will facilitate GSK's continued strong position in the global asthma/COPD market.
 For more information kindly visit :
 Related Reports
 Bristol-Myers Squibb Co.: PharmaVitae Profile
 Mitsubishi Tanabe Pharma Corp.: PharmaVitae Profile
 Contact us at :
 Bharat Book Bureau
 Tel: +91 22 27578668
 Fax: +91 22 27579131
 Follow us on twitter:!/BharatBook

Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Login to Submit Email

Author Info

Tag Cloud


More Releases


Add a Comment